Efforts underway to improve growth prospects for key markets

Company

10 Jan 2024 | 5 Min Read

Zydus Lifesciences is focusing on growth in key markets and niche portfolios.

Efforts are being made to enhance brand franchise and expand in emerging markets.

The company has a promising product pipeline for significant growth in the US market.

FY25 earnings forecast raised by 5% due to niche launches.

Expected strong YoY earnings growth in FY24 but modest growth in FY25.

Valued at 20x forward earnings with a price target of INR710.